BCL2 and Parkinson disease: A genome array study of frontal lobe in PD patients also demonstrated no specific gains or losses in SNCA but did detect CNVs unique to PD brains (versus controls) in other PD candidate genes (BCL2, NRSN1, and RYR2) [54].